menu search

in8bio to present new positive data from phase 1 trial of inb-100 at 2023 american society of hematology (ash) annual meeting

New data on the completed dose-escalation of this Phase 1 trial highlights promising efficacy of INB-100 in patients with hematologic malignancies; up...

November 2, 2023, 1:17 pm

in8bio to present new positive data from phase 1 trial of inb-100 at 2023 american society of hematology (ash) annual meeting

NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- in8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceut...

November 2, 2023, 9:17 am

in8bio, inc. (inab)'s technical outlook is bright after key golden cross

in8bio, Inc. (INAB) reached a significant support level, and could be a good pick for investors from a ...

June 5, 2023, 11:10 am

in8bio, inc. (inab) is up 37.87% in one week: what you should know

Does in8bio, Inc. (INAB) have what it takes to be a top stock pick for momentum investors? Let's find o...

May 24, 2023, 1:13 pm

in8bio announces new preclinical data in ovarian cancer to be presented at asgct 26th annual meeting

Preclinical data demonstrates that gamma-delta T cells have the ability to target other solid tumors such as ovarian cancer, supporting the developmen...

May 2, 2023, 9:08 pm

Why is in8bio (inab) stock up 9% today?

in8bio (NASDAQ: INAB ) stock is rising higher on Wednesday as the company's shares continue their wild ...

April 26, 2023, 8:30 am

in8bio stock price falls even as company receives fda orphan drug status for brain cancer treatment

in8bio (NASDAQ:INAB), Inc shares slid 16% to $2.51 in early Tuesday trading after the biopharmaceutical...

April 25, 2023, 10:40 am

What is going on with in8bio (inab) stock today?

in8bio (NASDAQ: INAB ) stock is on the move Tuesday as investors react to a recent rally and additional...

April 25, 2023, 9:36 am

in8bio to present new positive clinical data from phase 1 trial of inb-100 at ebmt 2023 annual meeting

NEW YORK, April 11, 2023 (GLOBE NEWSWIRE) -- in8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceu...

April 11, 2023, 8:00 am

in8bio to present at the h.c. wainwright cell therapy virtual conference

NEW YORK, Feb. 21, 2023 (GLOBE NEWSWIRE) -- in8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceut...

February 21, 2023, 7:00 am

in8bio to present positive early data from ongoing phase 1 study of inb-100 at the 64th american society of hematology annual meeting

NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- in8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceut...

November 3, 2022, 9:10 am

11 insiders tip more capital into in8bio and broker hc wainwright initiates with bullish $14 target

Clinical stage biopharmaceutical company in8bio Inc (US:INAB) topped the Fintel Significant Insider Bu...

September 6, 2022, 10:20 pm

Helix biopharma corp names dr gabrielle siegers as its head of research and development

Helix BioPharma Corp. (TSX:HBP) has announced the appointment of Dr Gabrielle Siegers as its head of research and development based out of the company...

September 2, 2022, 6:39 am

in8bio to present at july investor and scientific conferences

NEW YORK, June 30, 2022 (GLOBE NEWSWIRE) -- in8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceut...

June 30, 2022, 4:15 pm

in8bio to present at bio ceo & investor conference and next generation car-tcr summit

NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- in8bio, Inc. (Nasdaq: INAB), a clinical-stage gamma-delta T...

February 10, 2022, 5:36 pm

in8bio to present at bio ceo & investor conference and next generation car-tcr summit

NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- in8bio, Inc. (Nasdaq: INAB), a clinical-stage gamma-delta T...

February 10, 2022, 5:36 pm

in8bio to present at bio ceo & investor conference and next generation car-tcr summit

NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- in8bio, Inc. (Nasdaq: INAB), a clinical-stage gamma-delta T...

February 10, 2022, 5:36 pm

in8bio stock jumps after an update from leukemia trial

in8bio Inc (NASDAQ: INAB) has provided an update on the Phase 1 clinical trial of INB-100, a donor-d...

December 16, 2021, 1:06 pm

in8bio stock jumps after an update from leukemia trial

in8bio Inc (NASDAQ: INAB) has provided an update on the Phase 1 clinical trial of INB-100, a donor-d...

December 16, 2021, 1:06 pm

in8bio stock jumps after an update from leukemia trial

in8bio Inc (NASDAQ: INAB) has provided an update on the Phase 1 clinical trial of INB-100, a donor-d...

December 16, 2021, 1:06 pm


Search within

Pages Search Results: